An experimental drug designed to help
regulate the blood's iron supply shows promise
as a viable first
treatment for anemia
of inflammation, according to
results from the first human study
of the
treatment published online today in Blood, the Journal
of the American Society
of Hematology
(WASHINGTON, August, 27, 2014)-- An experimental drug designed to help
regulate the blood's iron supply shows promise
as a viable first
treatment for anemia
of inflammation, according to
results from the first human study
of the
treatment published online today in Blood, the Journal
of the American Society
of Hematology (ASH).